Pharmaceuticals market research reports by DelveInsight

• Ebola Virus- Competitive Landscape, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Ebola Virus- Competitive Landscape, 2024 DelveInsight’s, “Ebola Virus- Competitive landscape, 2024,” report provides comprehensive insights about 18+ companies and 20+ drugs in Ebola Virus Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, a ... Read More

• Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030 Immunohistochemistry (IHC) Market by Product Type (Instruments, Reagents & Kits, and Services), Application (Diagnostic, Research, and Forensic), End-User (Hospitals & Diagnostic Laboratories, Academic & R ... Read More

• Enteral Feeding Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Enteral Feeding Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Enteral Feeding Devices Market by Product Type (Enteral Feeding Pumps, Enteral Feeding Tubes [Enterostomy Feeding Tubes, Oroenteric Feeding Tubes, Nasoenteric Feeding Tubes {Nasogastric Feeding Tubes, Nasoje ... Read More

• Rett Syndrome - Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Rett Syndrome - Pipeline Insight, 2024 DelveInsight’s, “Rett Syndrome - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... Read More

• Helicobacter Pylori Infection - Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Helicobacter Pylori Infection - Pipeline Insight, 2024 DelveInsight’s, “Helicobacter Pylori Infection - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Helicobacter Pylori Infection pipeline landscape. It covers the pipeline drug profiles, ... Read More

• PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 5,000

  PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024 DelveInsight’s, “PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 200+ drugs in PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics assessment by ... Read More

• Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Ophthalmic Devices Market by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, a ... Read More

• Erectile Dysfunction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Erectile Dysfunction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Erectile Dysfunction Devices Market by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, and Others), Approach (Invasive, Non-Invasive), End-User (Hospitals and Clinics, Ambul ... Read More

• Psoriatic Arthritis - Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Psoriatic Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Psoriatic Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Deep Brain Stimulation Devices Market by Product Type (Single Channel and Dual Channel), Battery Type (Rechargeable and Non-Rechargeable), Application (Parkinson’s Disease, Epilepsy, Obsessive Compuls ... Read More

• Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030 Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals ... Read More

• Dengue Fever- Pipeline Insight, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Dengue Fever- Pipeline Insight, 2024 DelveInsight’s, “Dengue Fever- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Dengue Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More

• Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034

  Nov 11, 2024  |  Published by: DelveInsight  |  USD 7,950

  Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight’s “Autoimmune Psychosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Autoimmune Psychosis, historical and forecasted epidemiology as well as the ... Read More

• Schizophrenia - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Schizophrenia - Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More

• Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, there were an estimated 42 million prevalent cases of MASH in the 7MM. Out of these, a total of ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in t ... Read More

• Pre-Eclampsia - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Pre-Eclampsia - Pipeline Insight, 2024 DelveInsight’s, “Pre-Eclampsia - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Myotonic Dystrophy - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Myotonic Dystrophy - Pipeline Insight, 2024 DelveInsight’s, “Myotonic Dystrophy - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 27+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

• Lou Gehrig’s disease - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Lou Gehrig’s disease - Pipeline Insight, 2024 DelveInsight’s, “Lou Gehrig’s disease - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More

• Cutaneous T-cell lymphoma - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Type 2 Diabetes - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Type 2 Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Type 2 Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Type 2 Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 4 ... Read More

• Lupus Nephritis - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Smoking Cessation- Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More

• Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for ITP was estimated to be nearly USD 4,100 million in 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for ... Read More

• Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 1,028,651 diagnosed prevalent cases of NCFB in the 7MM. Of these, the US accounted for approximately 37% of the cases, EU4 and the ... Read More

< prev 3 4 5 6 7 8 9 10 11 12 next >